First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...
Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...
Lake Erie College of Osteopathic Medicine (LECOM) is reinforcing its commitment to accessible and affordable pharmacy ...
One again, the Zambia Institute for Tourism and Hospitality Studies (ZITHS) has pulled through another successful edition of ...
April 14, 2026 - PRESSADVANTAGE - All Pro Gutter Guards has announced the expansion of its service line to include ...
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...
By combining online academics with clinical simulation, a nationwide initiative is removing bottlenecks in radiologic ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced new in vitro findings demonstrating that izicopan ...
Microbial infections, caused by bacteria, viruses, and parasites, pose a significant challenge to global health, affecting millions annually. Despite advancements in medical science, understanding the ...
New York, New York - April 15, 2026 - PRESSADVANTAGE - Silverback AI Chatbot has announced an overview of its AI ...
As more care shifts outside hospital walls, health system leaders are rethinking how they plan, staff and structure their workforces to support a rapidly expanding ambulatory footprint. Outpatient ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. The defining contest of the 21st century is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results